Insights from 2023 ASCO® Annual Meeting


 

ASCO® 2023 Insights: "ASC2ESCALATE: A US Phase 2, Single-Arm, Dose-Escalation Study of Asciminib Monotherapy in Pts With CML-CP Previously Treated With 1 Prior TKI"

83 views
June 14, 2023
Comments 0
Login to view comments. Click here to Login